疗效和安全性-话题@MedSci

#疗效和安全性#

431篇内容 | 2642人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1720970, encodeId=49f41e2097045, content=<a href='/topic/show?id=634ee040179' target=_blank style='color:#2F92EE;'>#疗效和安全性#</a>, objectTitle=J Diabetes Investig：地格曲松/门冬胰岛素 VS 甘精胰岛素300 U/mL和甘精胰岛素的疗效和安全性, objectType=article, longId=201719, objectId=4d92201e1928, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4d92201e1928, replyNumber=0, likeNumber=61, createdTime=2021-04-27, rootId=0, userName=经常头晕, userId=16ef32982072, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4d92201e1928, moduleTitle=J Diabetes Investig：地格曲松/门冬胰岛素 VS 甘精胰岛素300 U/mL和甘精胰岛素的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4d92201e1928)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1720993, encodeId=58c71e2099381, content=<a href='/topic/show?id=634ee040179' target=_blank style='color:#2F92EE;'>#疗效和安全性#</a>, objectTitle=Cancer Discov：新型EGFR抑制剂Mobocertinib用于携带EGFRex20ins突变的NSCLC患者的疗效和安全性, objectType=article, longId=207727, objectId=85a920e727bb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=85a920e727bb, replyNumber=0, likeNumber=70, createdTime=2021-03-03, rootId=0, userName=经常头晕, userId=16ef32982072, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=85a920e727bb, moduleTitle=Cancer Discov：新型EGFR抑制剂Mobocertinib用于携带EGFRex20ins突变的NSCLC患者的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=85a920e727bb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1720989, encodeId=25171e20989a7, content=<a href='/topic/show?id=634ee040179' target=_blank style='color:#2F92EE;'>#疗效和安全性#</a>, objectTitle=JCEM：度拉糖肽对老年患者疗效和安全性分析, objectType=article, longId=206871, objectId=25072068e1d7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=25072068e1d7, replyNumber=0, likeNumber=74, createdTime=2021-09-13, rootId=0, userName=经常头晕, userId=16ef32982072, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=25072068e1d7, moduleTitle=JCEM：度拉糖肽对老年患者疗效和安全性分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=25072068e1d7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1720966, encodeId=37f61e20966d6, content=<a href='/topic/show?id=634ee040179' target=_blank style='color:#2F92EE;'>#疗效和安全性#</a>, objectTitle=JNNP：拉康酰胺辅助治疗原发性全身强直阵挛性癫痫的疗效和安全性：一项双盲、随机、安慰剂对照试验, objectType=article, longId=199805, objectId=d3371998058f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d3371998058f, replyNumber=0, likeNumber=85, createdTime=2021-07-07, rootId=0, userName=经常头晕, userId=16ef32982072, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d3371998058f, moduleTitle=JNNP：拉康酰胺辅助治疗原发性全身强直阵挛性癫痫的疗效和安全性：一项双盲、随机、安慰剂对照试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d3371998058f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1720990, encodeId=c3681e209908b, content=<a href='/topic/show?id=634ee040179' target=_blank style='color:#2F92EE;'>#疗效和安全性#</a>, objectTitle=Blood：Flotetuzumab作为难治性AML患者的补救免疫疗法的疗效和安全性, objectType=article, longId=207128, objectId=b43f20e12849, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b43f20e12849, replyNumber=0, likeNumber=72, createdTime=2021-12-17, rootId=0, userName=经常头晕, userId=16ef32982072, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b43f20e12849, moduleTitle=Blood：Flotetuzumab作为难治性AML患者的补救免疫疗法的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b43f20e12849)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1720961, encodeId=7a171e20961ce, content=<a href='/topic/show?id=634ee040179' target=_blank style='color:#2F92EE;'>#疗效和安全性#</a>, objectTitle=Ann Hematol：米卡芬素对非亲缘关系脐带血移植受者的疗效和安全性评价, objectType=article, longId=198105, objectId=f0bd19810522, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f0bd19810522, replyNumber=0, likeNumber=60, createdTime=2020-12-07, rootId=0, userName=经常头晕, userId=16ef32982072, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f0bd19810522, moduleTitle=Ann Hematol：米卡芬素对非亲缘关系脐带血移植受者的疗效和安全性评价, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f0bd19810522)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1720973, encodeId=bae41e209733f, content=<a href='/topic/show?id=634ee040179' target=_blank style='color:#2F92EE;'>#疗效和安全性#</a>, objectTitle=Lancet Rheumatol：西罗莫司治疗包涵体肌炎的疗效和安全性, objectType=article, longId=202177, objectId=1e4f2021e79d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1e4f2021e79d, replyNumber=0, likeNumber=62, createdTime=2021-03-28, rootId=0, userName=经常头晕, userId=16ef32982072, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1e4f2021e79d, moduleTitle=Lancet Rheumatol：西罗莫司治疗包涵体肌炎的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1e4f2021e79d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1720979, encodeId=642d1e209798e, content=<a href='/topic/show?id=634ee040179' target=_blank style='color:#2F92EE;'>#疗效和安全性#</a>, objectTitle=JAHA：直接口服抗凝剂对不同体重指数的房颤患者疗效和安全性分析, objectType=article, longId=204435, objectId=11a220443541, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=11a220443541, replyNumber=0, likeNumber=85, createdTime=2021-08-02, rootId=0, userName=经常头晕, userId=16ef32982072, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=11a220443541, moduleTitle=JAHA：直接口服抗凝剂对不同体重指数的房颤患者疗效和安全性分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=11a220443541)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1720988, encodeId=548b1e209881c, content=<a href='/topic/show?id=634ee040179' target=_blank style='color:#2F92EE;'>#疗效和安全性#</a>, objectTitle=Clin Cancer Res：新型抗PD-L1抗体LY3300054治疗晚期实体瘤的疗效和安全性, objectType=article, longId=206739, objectId=b029206e3989, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b029206e3989, replyNumber=0, likeNumber=65, createdTime=2021-08-17, rootId=0, userName=经常头晕, userId=16ef32982072, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b029206e3989, moduleTitle=Clin Cancer Res：新型抗PD-L1抗体LY3300054治疗晚期实体瘤的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b029206e3989)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1720997, encodeId=ac041e20997ad, content=<a href='/topic/show?id=634ee040179' target=_blank style='color:#2F92EE;'>#疗效和安全性#</a>, objectTitle=Ann Rheum Dis：法西单抗对慢性下腰痛的疗效和安全性, objectType=article, longId=208559, objectId=c7222085596a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c7222085596a, replyNumber=0, likeNumber=61, createdTime=2021-06-20, rootId=0, userName=经常头晕, userId=16ef32982072, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c7222085596a, moduleTitle=Ann Rheum Dis：法西单抗对慢性下腰痛的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c7222085596a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1720951, encodeId=bed51e2095173, content=<a href='/topic/show?id=634ee040179' target=_blank style='color:#2F92EE;'>#疗效和安全性#</a>, objectTitle=Lancet oncol：III期试验：ripretinib单药治疗晚期胃肠间质肿瘤的疗效和安全性, objectType=article, longId=195474, objectId=2d9e1954e445, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2d9e1954e445, replyNumber=0, likeNumber=70, createdTime=2021-04-22, rootId=0, userName=经常头晕, userId=16ef32982072, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2d9e1954e445, moduleTitle=Lancet oncol：III期试验：ripretinib单药治疗晚期胃肠间质肿瘤的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2d9e1954e445)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1721000, encodeId=1b911e2100018, content=<a href='/topic/show?id=634ee040179' target=_blank style='color:#2F92EE;'>#疗效和安全性#</a>, objectTitle=JNNP：阿来组单抗治疗多发性硬化患者对疗效和安全性结局的影响, objectType=article, longId=209061, objectId=5fe7209061ad, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5fe7209061ad, replyNumber=0, likeNumber=66, createdTime=2021-11-14, rootId=0, userName=经常头晕, userId=16ef32982072, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5fe7209061ad, moduleTitle=JNNP：阿来组单抗治疗多发性硬化患者对疗效和安全性结局的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5fe7209061ad)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1720957, encodeId=8b911e20957ef, content=<a href='/topic/show?id=634ee040179' target=_blank style='color:#2F92EE;'>#疗效和安全性#</a>, objectTitle=JAHA：高胆固醇血症患者贝派地酸的疗效和安全性, objectType=article, longId=197927, objectId=a35c19e9276c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a35c19e9276c, replyNumber=0, likeNumber=70, createdTime=2020-11-02, rootId=0, userName=经常头晕, userId=16ef32982072, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a35c19e9276c, moduleTitle=JAHA：高胆固醇血症患者贝派地酸的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a35c19e9276c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1720996, encodeId=c59b1e209966d, content=<a href='/topic/show?id=634ee040179' target=_blank style='color:#2F92EE;'>#疗效和安全性#</a>, objectTitle=Ann Rheum Dis：类风湿性关节炎换用阿达木单抗或乌帕替尼治疗的疗效和安全性, objectType=article, longId=208557, objectId=2da320855e15, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2da320855e15, replyNumber=0, likeNumber=74, createdTime=2021-07-26, rootId=0, userName=经常头晕, userId=16ef32982072, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2da320855e15, moduleTitle=Ann Rheum Dis：类风湿性关节炎换用阿达木单抗或乌帕替尼治疗的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2da320855e15)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1720976, encodeId=1d361e20976ca, content=<a href='/topic/show?id=634ee040179' target=_blank style='color:#2F92EE;'>#疗效和安全性#</a>, objectTitle=Ann Rheum Dis：阿巴西普对活动性原发性干燥综合征的疗效和安全性, objectType=article, longId=203271, objectId=e4be2032e1ba, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e4be2032e1ba, replyNumber=0, likeNumber=83, createdTime=2021-07-30, rootId=0, userName=经常头晕, userId=16ef32982072, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e4be2032e1ba, moduleTitle=Ann Rheum Dis：阿巴西普对活动性原发性干燥综合征的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e4be2032e1ba)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1720962, encodeId=40b31e20962cd, content=<a href='/topic/show?id=634ee040179' target=_blank style='color:#2F92EE;'>#疗效和安全性#</a>, objectTitle=Oral Dis：改良多西他赛加顺铂和5-氟尿嘧啶（TPF）在中国SCCHN患者中的疗效和安全性, objectType=article, longId=198495, objectId=ee0919849563, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ee0919849563, replyNumber=0, likeNumber=81, createdTime=2020-11-01, rootId=0, userName=经常头晕, userId=16ef32982072, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ee0919849563, moduleTitle=Oral Dis：改良多西他赛加顺铂和5-氟尿嘧啶（TPF）在中国SCCHN患者中的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ee0919849563)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1720978, encodeId=84331e2097843, content=<a href='/topic/show?id=634ee040179' target=_blank style='color:#2F92EE;'>#疗效和安全性#</a>, objectTitle=Lancet oncol：帕比司他联合皮下给予硼替佐米治疗复发性/难治性多发性骨髓瘤的疗效和安全性, objectType=article, longId=204420, objectId=fbc5204420da, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fbc5204420da, replyNumber=0, likeNumber=66, createdTime=2021-10-31, rootId=0, userName=经常头晕, userId=16ef32982072, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fbc5204420da, moduleTitle=Lancet oncol：帕比司他联合皮下给予硼替佐米治疗复发性/难治性多发性骨髓瘤的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fbc5204420da)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1720965, encodeId=9db31e2096563, content=<a href='/topic/show?id=634ee040179' target=_blank style='color:#2F92EE;'>#疗效和安全性#</a>, objectTitle=Lancet gastroenterol hepatol：鲁比前列酮治疗便秘的非酒精性脂肪性肝病患者的疗效和安全性, objectType=article, longId=199610, objectId=27e819961026, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=27e819961026, replyNumber=0, likeNumber=53, createdTime=2021-04-04, rootId=0, userName=经常头晕, userId=16ef32982072, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=27e819961026, moduleTitle=Lancet gastroenterol hepatol：鲁比前列酮治疗便秘的非酒精性脂肪性肝病患者的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=27e819961026)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1720980, encodeId=5fdb1e2098037, content=<a href='/topic/show?id=634ee040179' target=_blank style='color:#2F92EE;'>#疗效和安全性#</a>, objectTitle=Gastroenterology：神经激肽-1受体抑制剂Tradipitant对糖尿病性和特发性胃轻瘫患者的疗效和安全性分析, objectType=article, longId=204727, objectId=e076204e2720, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e076204e2720, replyNumber=0, likeNumber=46, createdTime=2021-04-12, rootId=0, userName=经常头晕, userId=16ef32982072, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e076204e2720, moduleTitle=Gastroenterology：神经激肽-1受体抑制剂Tradipitant对糖尿病性和特发性胃轻瘫患者的疗效和安全性分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e076204e2720)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1720967, encodeId=7db51e20967bc, content=<a href='/topic/show?id=634ee040179' target=_blank style='color:#2F92EE;'>#疗效和安全性#</a>, objectTitle=Blood：Mavorixafor治疗WHIM综合征的疗效和安全性, objectType=article, longId=200351, objectId=47c320035124, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=47c320035124, replyNumber=0, likeNumber=58, createdTime=2021-01-22, rootId=0, userName=经常头晕, userId=16ef32982072, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=47c320035124, moduleTitle=Blood：Mavorixafor治疗WHIM综合征的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=47c320035124)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

疗效和安全性

2020-05-29

经常头晕 (审核中...)

前往app查看评论内容

#疗效和安全性#

J Diabetes Investig：地格曲松/门冬胰岛素 VS 甘精胰岛素300 U/mL和甘精胰岛素的疗效和安全性

2021-04-27

经常头晕 (审核中...)

前往app查看评论内容

#疗效和安全性#

Cancer Discov：新型EGFR抑制剂Mobocertinib用于携带EGFRex20ins突变的NSCLC患者的疗效和安全性

2021-03-03

经常头晕 (审核中...)

前往app查看评论内容

#疗效和安全性#

JCEM：度拉糖肽对老年患者疗效和安全性分析

2021-09-13

经常头晕 (审核中...)

前往app查看评论内容

#疗效和安全性#

JNNP：拉康酰胺辅助治疗原发性全身强直阵挛性癫痫的疗效和安全性：一项双盲、随机、安慰剂对照试验

2021-07-07

经常头晕 (审核中...)

前往app查看评论内容

#疗效和安全性#

Blood：Flotetuzumab作为难治性AML患者的补救免疫疗法的疗效和安全性

2021-12-17

经常头晕 (审核中...)

前往app查看评论内容

#疗效和安全性#

Ann Hematol：米卡芬素对非亲缘关系脐带血移植受者的疗效和安全性评价

2020-12-07

经常头晕 (审核中...)

前往app查看评论内容

#疗效和安全性#

Lancet Rheumatol：西罗莫司治疗包涵体肌炎的疗效和安全性

2021-03-28

经常头晕 (审核中...)

前往app查看评论内容

#疗效和安全性#

JAHA：直接口服抗凝剂对不同体重指数的房颤患者疗效和安全性分析

2021-08-02

经常头晕 (审核中...)

前往app查看评论内容

#疗效和安全性#

Clin Cancer Res：新型抗PD-L1抗体LY3300054治疗晚期实体瘤的疗效和安全性

2021-08-17

经常头晕 (审核中...)

前往app查看评论内容

#疗效和安全性#

Ann Rheum Dis：法西单抗对慢性下腰痛的疗效和安全性

2021-06-20

经常头晕 (审核中...)

前往app查看评论内容

#疗效和安全性#

Lancet oncol：III期试验：ripretinib单药治疗晚期胃肠间质肿瘤的疗效和安全性

2021-04-22

经常头晕 (审核中...)

前往app查看评论内容

#疗效和安全性#

JNNP：阿来组单抗治疗多发性硬化患者对疗效和安全性结局的影响

2021-11-14

经常头晕 (审核中...)

前往app查看评论内容

#疗效和安全性#

JAHA：高胆固醇血症患者贝派地酸的疗效和安全性

2020-11-02

经常头晕 (审核中...)

前往app查看评论内容

#疗效和安全性#

Ann Rheum Dis：类风湿性关节炎换用阿达木单抗或乌帕替尼治疗的疗效和安全性

2021-07-26

经常头晕 (审核中...)

前往app查看评论内容

#疗效和安全性#

Ann Rheum Dis：阿巴西普对活动性原发性干燥综合征的疗效和安全性

2021-07-30

经常头晕 (审核中...)

前往app查看评论内容

#疗效和安全性#

Oral Dis：改良多西他赛加顺铂和5-氟尿嘧啶（TPF）在中国SCCHN患者中的疗效和安全性

2020-11-01

经常头晕 (审核中...)

前往app查看评论内容

#疗效和安全性#

Lancet oncol：帕比司他联合皮下给予硼替佐米治疗复发性/难治性多发性骨髓瘤的疗效和安全性

2021-10-31

经常头晕 (审核中...)

前往app查看评论内容

#疗效和安全性#

Lancet gastroenterol hepatol：鲁比前列酮治疗便秘的非酒精性脂肪性肝病患者的疗效和安全性

2021-04-04

经常头晕 (审核中...)

前往app查看评论内容

#疗效和安全性#

Gastroenterology：神经激肽-1受体抑制剂Tradipitant对糖尿病性和特发性胃轻瘫患者的疗效和安全性分析

2021-04-12

经常头晕 (审核中...)

前往app查看评论内容

#疗效和安全性#

Blood：Mavorixafor治疗WHIM综合征的疗效和安全性

2021-01-22

科室
- - 订阅+
  - 更多科室
工具
服务